<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Cerebrolysin</title><link>https://peptidescanner.com/peptides/cerebrolysin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Cerebrolysin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/cerebrolysin.xml" rel="self" type="application/rss+xml"/><item><title>Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.</title><link>https://peptidescanner.com/stories/pubmed-pmid-43030876-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-43030876-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-43030876-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-17</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00840671</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00840671-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00840671-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00840671-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2010-12-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00868283</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00868283-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00868283-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00868283-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-12-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00947531</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00947531-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00947531-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00947531-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-02-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01059461</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01059461-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01059461-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct01059461-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-09-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01388738</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01388738-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01388738-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct01388738-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-12-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02149875</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02149875-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02149875-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct02149875-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-08-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02768571</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02768571-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02768571-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct02768571-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-09-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03480698</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03480698-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03480698-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct03480698-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-02-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03506841</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03506841-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03506841-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct03506841-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-03-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04427241</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04427241-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04427241-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04427241-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-05-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04751136</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04751136-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04751136-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04751136-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-02-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04830943</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04830943-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04830943-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04830943-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-01-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05288465</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05288465-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05288465-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05288465-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-03-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05755997</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05755997-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05755997-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05755997-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-02-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05807503</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05807503-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05807503-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05807503-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-04-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05821075</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05821075-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05821075-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05821075-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-07-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06052787</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06052787-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06052787-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06052787-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-11-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06208540</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06208540-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06208540-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06208540-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-08-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06339411</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06339411-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06339411-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06339411-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06677502</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06677502-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06677502-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06677502-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-12-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07846488</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07846488-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07846488-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct07846488-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-11738849-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-11738849-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-11738849-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin: a review of its use in dementia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19848437-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19848437-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-19848437-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20393954-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20393954-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-20393954-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].</title><link>https://peptidescanner.com/stories/pubmed-pmid-21350421-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21350421-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-21350421-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-11-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for vascular dementia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23440834-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23440834-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-23440834-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Cerebrolysin for acute ischemic stroke].</title><link>https://peptidescanner.com/stories/pubmed-pmid-23805635-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23805635-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-23805635-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-04-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24730284-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24730284-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-24730284-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Cerebrolysin in the treatment of brain injuries of moderate severity].</title><link>https://peptidescanner.com/stories/pubmed-pmid-25591645-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25591645-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-25591645-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-11-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26083192-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26083192-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-26083192-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27918088-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27918088-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-27918088-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28430363-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28430363-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-28430363-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29155000-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29155000-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-29155000-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-02-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin: a multi-target drug for recovery after stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30004268-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30004268-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-30004268-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-05-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for vascular dementia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31710397-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31710397-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-31710397-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-09-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32662068-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32662068-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-32662068-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-05-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer&apos;s disease: 30 years of clinical use.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32808294-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32808294-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-32808294-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-10-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33223037-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33223037-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-33223037-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-11-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33620612-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33620612-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-33620612-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36979317-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36979317-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-36979317-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-03-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37522695-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37522695-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37522695-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-08-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin for acute ischaemic stroke.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37818733-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37818733-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37818733-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37892776-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37892776-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37892776-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39832667-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39832667-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-39832667-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-06-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial].</title><link>https://peptidescanner.com/stories/pubmed-pmid-40577185-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-40577185-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-40577185-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41349847-cerebrolysin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41349847-cerebrolysin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-41349847-cerebrolysin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
